RAC 2.92% $1.94 race oncology ltd

Ann: Breakthrough Zantrene Heart Protection Discovery, page-110

  1. 175 Posts.
    lightbulb Created with Sketch. 32
    DrT, I figure the risk of successful translation from lab to humans is relatively low here compared to FTO lab results. Can you tell us about that. Why (if so) can we be more confident that these lab results will prove up in human trials.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.